MedPath

Multicentre Randomised trial of Ghrelin in anterior circulation ischemic stroke treated with endovascular thrombectomy. A randomized phase 2 trial

Phase 2
Conditions
ischemic stroke
10007963
Registration Number
NL-OMON51856
Lead Sponsor
Rijnstate Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

- a clinical diagnosis of acute ischemic stroke, caused by intracranial large
vessel occlusion of the anterior circulation (distal intracranial carotid
artery or middle (M1/proximal M2) cerebral artery) confirmed by neuro-imaging
(CTA or MRA),
- treatment with EVT, defined as groin puncture in the angio suite,
- CT or MRI ruling out intracranial hemorrhage,
- a pre-EVT score of at least 10 on the NIHSS,
- age of 18 years or older,
- written informed consent.

Exclusion Criteria

- pre-stroke disability defined as mRS >=2,
- life expectancy shorter than one year,
- child bearing potential.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath